BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24264800)

  • 1. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
    Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
    J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Cell Tissue Res; 2013 Nov; 354(2):521-32. PubMed ID: 23881403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
    Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
    Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Liu QF; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):916-21. PubMed ID: 24433772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
    Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
    J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
    Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
    J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of Gli1 in the invasion and migration of pancreatic cancer cells].
    Sheng W; Dong M; Zhou J; Liu Q; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2014 Jul; 52(7):518-22. PubMed ID: 25262609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
    Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
    FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin Promotes Proliferation and Migration But Inhibits Apoptosis in Schwann Cells.
    Huang G; Sun Z; Wu J; Shui S; Han X; Guo D; Li T
    Med Sci Monit; 2016 Nov; 22():4516-4522. PubMed ID: 27876711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
    Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
    Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.
    Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R
    Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
    Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
    Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.
    Liu QG; Li YJ; Yao L
    Pancreatology; 2018 Sep; 18(6):678-688. PubMed ID: 30055941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 in pancreatic cancer and its significance.
    Li XP; Zhang XW; Zheng LZ; Guo WJ
    Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin promotes migration and invasion of esophageal cancer cells by upregulating neuropilin-1 expression via STAT5A.
    Shi F; Shang L; Pan BQ; Wang XM; Jiang YY; Hao JJ; Zhang Y; Cai Y; Xu X; Zhan QM; Wang MR
    Clin Cancer Res; 2014 Dec; 20(23):6153-62. PubMed ID: 25231404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
    Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinicopathological significance of the expression of calreticulin in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):58-61. PubMed ID: 23578430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.